Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (441-450 of 535) with videos related to

Pageof 54
Sort By:
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Sexually dimorphic placental responses to maternal SARS-CoV-2 infectionEvan A Bordt, Lydia L Shook, Caroline Atyeo, et al.
JAMA|May 13, 2021
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating WomenAi-Ris Y Collier, Katherine McMahan, Jingyou Yu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2024
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort studyZoe Swank, Ella Borberg, Yulu Chen, et al.
Plos Pathogens|April 29, 2020
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and typeLuca Schifanella, Susan W Barnett, Massimiliano Bissa, et al.
Plos Pathogens|December 4, 2019
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and typeLuca Schifanella, Susan W Barnett, Massimiliano Bissa, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Cell|January 21, 2021
Compromised SARS-CoV-2-specific placental antibody transferCaroline Atyeo, Krista M Pullen, Evan A Bordt, et al.
Science Translational Medicine|October 19, 2021
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responsesEvan A Bordt, Lydia L Shook, Caroline Atyeo, et al.
Pageof 54

Showing results (441-450 of 535) with videos related to

Sort By:
Pageof 54
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Sexually dimorphic placental responses to maternal SARS-CoV-2 infectionEvan A Bordt, Lydia L Shook, Caroline Atyeo, et al.
JAMA|May 13, 2021
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating WomenAi-Ris Y Collier, Katherine McMahan, Jingyou Yu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 10, 2024
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort studyZoe Swank, Ella Borberg, Yulu Chen, et al.
Plos Pathogens|April 29, 2020
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and typeLuca Schifanella, Susan W Barnett, Massimiliano Bissa, et al.
Plos Pathogens|December 4, 2019
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and typeLuca Schifanella, Susan W Barnett, Massimiliano Bissa, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Cell|January 21, 2021
Compromised SARS-CoV-2-specific placental antibody transferCaroline Atyeo, Krista M Pullen, Evan A Bordt, et al.
Science Translational Medicine|October 19, 2021
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responsesEvan A Bordt, Lydia L Shook, Caroline Atyeo, et al.
Pageof 54